
    
      In a prospective, randomized, double blind, controlled, long-term study, investigators assign
      40 depressed patients, in remission after ECT course associated to venlafaxine, with lithium
      adjunction after ECT course, either to tDCS or sham tDCS. Depressive symptoms and cognition
      were assessed after acute ECT after six months of continuation therapy.
    
  